PHENELZINE SULFATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1961)
Entry Type: Small molecule
Molecule Category: Salt
UNII: 2681D7P965
Parent Compound: PHENELZINE

Structure
InChI Key RXBKMJIPNDOHFR-UHFFFAOYSA-N
Smile NNCCc1ccccc1.O=S(=O)(O)O
InChI
InChI=1S/C8H12N2.H2O4S/c9-10-7-6-8-4-2-1-3-5-8;1-5(2,3)4/h1-5,10H,6-7,9H2;(H2,1,2,3,4)

Physicochemical Descriptors

Property Name Value
Molecular Formula C8H14N2O4S
Molecular Weight 234.28
AlogP 0.69
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 3.0
Polar Surface Area 38.05
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 10.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Monoamine oxidase inhibitor FDA Wikipedia
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 111

Metabolites

visNetwork

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Prostatic Neoplasms 2 D011471 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Related Entries

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
18.82
General disorders and administration site conditions
17.55
Psychiatric disorders
13.07
Injury, poisoning and procedural complications
7.55
Vascular disorders
7.47
Investigations
5.72
Gastrointestinal disorders
5.56
Cardiac disorders
4.44
Musculoskeletal and connective tissue disorders
4.04
Skin and subcutaneous tissue disorders
2.48
Metabolism and nutrition disorders
2.12

Cross References

Resources Reference
ChEBI 8061
ChEMBL CHEMBL1200895
EPA CompTox DTXSID3021144
FDA SRS 2681D7P965
Guide to Pharmacology 7266
KEGG C07431
PubChem 61100
SureChEMBL SCHEMBL40652
ZINC ZINC19166991
CONTENTS